A surgically implanted device used to regulate bladder and bowel control often requires additional operations to repair or replace it, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
The device, a...
FIND A PHYSICIAN
Search for a WCMC provider by name, insurance accepted, or treatment location.
Search
SPOTLIGHT
Learn more about some of the department's current news, events, or areas of focus.
ExploreFaculty members from Weill Cornell Medicine's Department of Urology have submitted over 100 abstracts and will be presenting over 50 of these at the upcoming 2018 American Urological Association Annual Meeting, the largest scientific meeting in the world that reflects the most important advances in the field. The Department's faculty members,...
In January 2018, the Prostate Cancer Foundation recognized the developments of PSMA radionuclide therapy as one of the top 5 research stories of 2017, highlighting the recent work from Weill Cornell Medicine’s Department of Urology as a driving force behind this effort.
Researchers at Weill Cornell Medicine, including Drs....
We are proud to announce that Dr. Joseph Del Pizzo has been named to an endowed faculty position by the Board of Overseers, as recommended by Dean Choi. Dr. Del Pizzo has been appointed the E. Darracott Vaughan, Jr. Associate Professor of Urology and maintains his Associate Professorship of Urology as well as Associate...
...
Dr. Peter Schlegel, Chairman of Urology at Weill Cornell Medicine, was featured in Newsweek, discussing the potential for a male birth control pill that would temporarily stop sperm production. Dr. Schlegel comments on recent research that lays a "genetic foundation for male birth control" in an animal study. He...
Dr. Darius Paduch of Weill Cornell Urology is featured for expert urologist commentary in this SELF.com article that discusses the health questions surrounding usage of penis stickers.
The article discusses the effictiveness of...
If you would like to make an appointment for a male sexual and reproductive medicine consultation in New York City at Weill Cornell Medicine, please call our office at (212) 746-5309.
In this video, urologist James A. Kashanian, M.D. speaks about the daily accomplishments that he achieves as a practicing physician...
Michael Augello, Ph.D. was named as a recipient of the Prostate Cancer Foundation's 2017 Young Investigator Awards. Dr. Augello is a post-doc working with Dr. Christopher Barbieri in Urology at Weill Cornell Medicine....
It’s no exaggeration to say that Julia Roudi now has a new lease on life. After experiencing discomfort for decades, Julie, at 63, is now able to walk as far and as long as she wants, as well as enjoy more comfortable, fuller days.
Julia suffered from a severely prolapsed uterus and bladder and, like many women, thought it was something...
Marc Goldstein, MD, DSc (hon), FACS discusses his role as a urologist, surgeon and pioneer in male infertility evaluation and treatment at Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York City. To make an appointment with Dr. Goldstein in NYC, please call his office at (212) 746-5470.
For more information on Dr. Goldstein,...
NewYork-Presbyterian and Weill Cornell Medicine clinicians in progress on Phase 1 clinical trial of PSMA-Targeted Therapeutic Agent for the Treatment for Metastatic Prostate Cancer
NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the...
In May 2016, Dr. Jonathan Shoag with Drs. Mittal and Hu of Weill Cornell Medicine / NewYork-Presbyterian Hospital reported in the New England Journal of Medicine ...
Female pelvic floor disorders—including incontinence, pelvic organ prolapse, urinary tract infections, fistulas, and others—can significantly impact one’s quality of life and, as the population ages, are becoming more common. In fact, 300,000 prolapse repairs and 100,000 urinary incontinence procedures were performed in the past year alone....
Introducing Dr. Patrick Culligan,
Director of Urogynecology at the Center for Female Pelvic Health,
Weill Cornell Medicine
...
In a 2014 modeling study published in Cancer, Gulati and colleagues predicted that if PSA screening continued at its current rate, 710,000 to 1.1 million men would be overdiagnosed between 2013 and 2025, but that 36,000 to 57,000 prostate cancer deaths would be prevented during that period.
"That study showed that, if screenings really...
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave the way for new targeted treatment approaches.
A mutation of the gene Speckle Type BTB/POZ Protein, or SPOP,...
Jim C. Hu, M.D., M.P.H. discusses various minimally-invasive and non-surgical treatment options under the umbrella term of partial gland ablation.
Dr. Hu speaks about techniques & practical outcomes of various partial ablation procedures performed for men with prostate cancer, most...
Jim C. Hu, MD, MPH talks prostate cancer, evaluation of elevated PSA, targeted sampling of prostate tissue using MRI-Ultrasound fusion guided biopsy, as well as prostate MRI, PIRADS scoring and biomarkers.
Dr. Christopher Barbieri speaks at an US TOO prostate cancer educational seminar at Weill Cornell Medicine to discuss the role of genomics in the identification and treatment of specific subtypes of prostate cancer, precision medicine tactics, as well as emerging therapies.
Dr. Christopher Barbieri was the type of kid who would press every button in the house, much to his parents’ chagrin. Ultimately he learned to put that inquisitiveness to good use as a doctor and scientist, and discovered a new form of prostate cancer.
“My approach to the...
Therapeutic agent developed by Neil Bander, MD, Weill Cornell Urology Physician Scientist, shows promise in new trials to provide treatment for advanced prostate cancer.
PSMA radioligand therapy, developed at Weill Cornell...
Expert opinion / commentary written by Dr. Peter Schlegel.
Since articles were published in 2014 suggesting potential cardiovascular risks associated with testosterone replacement therapy, substantial concern has been expressed regarding the use of testosterone in men with aging-associated hypogonadism, also...
MULTIMEDIA
Watch videos about conditions, read department news, or review articles and research.
View All
Dr. Jim Hu - Robotics Involved in Most Urologic Cancer Surgeries
06/07/2018
Renal and Urology News provided coverage of an abstract from the 2018 AUA Annual Meeting regarding the prevalence of robotic assistance in urologic surgery cases, which features Dr. Jim C. Hu for external commentary:
"The findings are supportive of robotic vs open surgery similar to the individual studies that...
VIEW
Dr. Goldstein receives the 2018 Distinguished Reproductive Urology Award
05/29/2018
Please join us in congratulating Dr. Marc Goldstein for receiving the 2018 Distinguished Reproductive Urology Award from the Society for the Study of Male Reproduction (SSMR). Dr. Goldstein was presented with this prestigious award during the 2018 AUA Annual Meeting in...
VIEW
Weill Cornell Urology at the AUA 2018 Annual Meeting
05/17/2018
Faculty members from Weill Cornell Medicine's Department of Urology have submitted over 100 abstracts and will be presenting over 50 of these at the upcoming 2018 American Urological Association Annual Meeting, the largest scientific meeting in the world that reflects the most important advances in the field. The Department's faculty members,...
VIEW
Treating prostate cancer with cryotherapy: Richard Hayden's success
04/26/2018
Richard Hayden is a quick-witted 80-year-old living in Manhattan. He enjoys being healthy and active; taking advantage of all that New York City has to offer during his retired years.
Earlier this year, during a routine visit with his primary care physician, he was told that his prostate-specific antigen (referred to as "PSA") levels were...
VIEW
Cryotherapy and prostate cancer
04/25/2018
If you've been diagnosed with prostate cancer, determining your treatment plan can be stressful and overwhelming. There is no single "best" course of action; it depends on you, your lifestyle goals, and your specific type of cancer.
Prostate cancer can be treated with active surveillance, radiation therapy, medical & hormone...
OUR LOCATIONS
Faculty members from Weill Cornell Medicine's Department of Urology have submitted over 100 abstracts and will be presenting over 50 of these at the upcoming 2018 American Urological Association Annual Meeting, the largest scientific meeting in the world that reflects the most important advances in the field. The Department's faculty members,...
A surgically implanted device used to regulate bladder and bowel control often requires additional operations to repair or replace it, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
The device, a...
In January 2018, the Prostate Cancer Foundation recognized the developments of PSMA radionuclide therapy as one of the top 5 research stories of 2017, highlighting the recent work from Weill Cornell Medicine’s Department of Urology as a driving force behind this effort.
Researchers at Weill Cornell Medicine, including Drs....
We are proud to announce that Dr. Joseph Del Pizzo has been named to an endowed faculty position by the Board of Overseers, as recommended by Dean Choi. Dr. Del Pizzo has been appointed the E. Darracott Vaughan, Jr. Associate Professor of Urology and maintains his Associate Professorship of Urology as well as Associate...
...
Dr. Peter Schlegel, Chairman of Urology at Weill Cornell Medicine, was featured in Newsweek, discussing the potential for a male birth control pill that would temporarily stop sperm production. Dr. Schlegel comments on recent research that lays a "genetic foundation for male birth control" in an animal study. He...
Dr. Darius Paduch of Weill Cornell Urology is featured for expert urologist commentary in this SELF.com article that discusses the health questions surrounding usage of penis stickers.
The article discusses the effictiveness of...
If you would like to make an appointment for a male sexual and reproductive medicine consultation in New York City at Weill Cornell Medicine, please call our office at (212) 746-5309.
In this video, urologist James A. Kashanian, M.D. speaks about the daily accomplishments that he achieves as a practicing physician...
Michael Augello, Ph.D. was named as a recipient of the Prostate Cancer Foundation's 2017 Young Investigator Awards. Dr. Augello is a post-doc working with Dr. Christopher Barbieri in Urology at Weill Cornell Medicine....
It’s no exaggeration to say that Julia Roudi now has a new lease on life. After experiencing discomfort for decades, Julie, at 63, is now able to walk as far and as long as she wants, as well as enjoy more comfortable, fuller days.
Julia suffered from a severely prolapsed uterus and bladder and, like many women, thought it was something...
Marc Goldstein, MD, DSc (hon), FACS discusses his role as a urologist, surgeon and pioneer in male infertility evaluation and treatment at Weill Cornell Medicine/NewYork-Presbyterian Hospital in New York City. To make an appointment with Dr. Goldstein in NYC, please call his office at (212) 746-5470.
For more information on Dr. Goldstein,...
NewYork-Presbyterian and Weill Cornell Medicine clinicians in progress on Phase 1 clinical trial of PSMA-Targeted Therapeutic Agent for the Treatment for Metastatic Prostate Cancer
NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the...
In May 2016, Dr. Jonathan Shoag with Drs. Mittal and Hu of Weill Cornell Medicine / NewYork-Presbyterian Hospital reported in the New England Journal of Medicine ...
Female pelvic floor disorders—including incontinence, pelvic organ prolapse, urinary tract infections, fistulas, and others—can significantly impact one’s quality of life and, as the population ages, are becoming more common. In fact, 300,000 prolapse repairs and 100,000 urinary incontinence procedures were performed in the past year alone....
Introducing Dr. Patrick Culligan,
Director of Urogynecology at the Center for Female Pelvic Health,
Weill Cornell Medicine
...
In a 2014 modeling study published in Cancer, Gulati and colleagues predicted that if PSA screening continued at its current rate, 710,000 to 1.1 million men would be overdiagnosed between 2013 and 2025, but that 36,000 to 57,000 prostate cancer deaths would be prevented during that period.
"That study showed that, if screenings really...
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave the way for new targeted treatment approaches.
A mutation of the gene Speckle Type BTB/POZ Protein, or SPOP,...
Jim C. Hu, M.D., M.P.H. discusses various minimally-invasive and non-surgical treatment options under the umbrella term of partial gland ablation.
Dr. Hu speaks about techniques & practical outcomes of various partial ablation procedures performed for men with prostate cancer, most...
Jim C. Hu, MD, MPH talks prostate cancer, evaluation of elevated PSA, targeted sampling of prostate tissue using MRI-Ultrasound fusion guided biopsy, as well as prostate MRI, PIRADS scoring and biomarkers.
Dr. Christopher Barbieri speaks at an US TOO prostate cancer educational seminar at Weill Cornell Medicine to discuss the role of genomics in the identification and treatment of specific subtypes of prostate cancer, precision medicine tactics, as well as emerging therapies.
Dr. Christopher Barbieri was the type of kid who would press every button in the house, much to his parents’ chagrin. Ultimately he learned to put that inquisitiveness to good use as a doctor and scientist, and discovered a new form of prostate cancer.
“My approach to the...
Therapeutic agent developed by Neil Bander, MD, Weill Cornell Urology Physician Scientist, shows promise in new trials to provide treatment for advanced prostate cancer.
PSMA radioligand therapy, developed at Weill Cornell...
Expert opinion / commentary written by Dr. Peter Schlegel.
Since articles were published in 2014 suggesting potential cardiovascular risks associated with testosterone replacement therapy, substantial concern has been expressed regarding the use of testosterone in men with aging-associated hypogonadism, also...
Dr. Jim Hu - Robotics Involved in Most Urologic Cancer Surgeries
06/07/2018
Renal and Urology News provided coverage of an abstract from the 2018 AUA Annual Meeting regarding the prevalence of robotic assistance in urologic surgery cases, which features Dr. Jim C. Hu for external commentary:
"The findings are supportive of robotic vs open surgery similar to the individual studies that...
VIEW
Dr. Goldstein receives the 2018 Distinguished Reproductive Urology Award
05/29/2018
Please join us in congratulating Dr. Marc Goldstein for receiving the 2018 Distinguished Reproductive Urology Award from the Society for the Study of Male Reproduction (SSMR). Dr. Goldstein was presented with this prestigious award during the 2018 AUA Annual Meeting in...
VIEW
Weill Cornell Urology at the AUA 2018 Annual Meeting
05/17/2018
Faculty members from Weill Cornell Medicine's Department of Urology have submitted over 100 abstracts and will be presenting over 50 of these at the upcoming 2018 American Urological Association Annual Meeting, the largest scientific meeting in the world that reflects the most important advances in the field. The Department's faculty members,...
VIEW
Treating prostate cancer with cryotherapy: Richard Hayden's success
04/26/2018
Richard Hayden is a quick-witted 80-year-old living in Manhattan. He enjoys being healthy and active; taking advantage of all that New York City has to offer during his retired years.
Earlier this year, during a routine visit with his primary care physician, he was told that his prostate-specific antigen (referred to as "PSA") levels were...
VIEW
Cryotherapy and prostate cancer
04/25/2018
If you've been diagnosed with prostate cancer, determining your treatment plan can be stressful and overwhelming. There is no single "best" course of action; it depends on you, your lifestyle goals, and your specific type of cancer.
Prostate cancer can be treated with active surveillance, radiation therapy, medical & hormone...
Our Locations
